RNA detection is mainstreamed in USA, Europe and Japan, etc. The experience with non-invasive urine test is irreplaceable for patients.
Respiratory Diseases requires methods which enable earlier and accurate detection as they develop and spread rapidly
The outbreak of HFMD requests testing which is fast, accurate and able to discriminate main subtypes.
These diseases remain a global public health problem, but RNA is a promising biomarker for improving clinical diagnosis and patients' outcome.
Telephone:021-50720200
Email:sales@rdbio.com
Fax:021-50720186
Address:Block A, building 15, NO.528 Ruiqing Road, East District, Zhangjiang High Tech Park, Shanghai, P.R .China